• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM Back to Search Results
Model Number NX1000-3
Device Problem Insufficient Information (3190)
Patient Problem Respiratory Distress (2045)
Event Date 07/12/2017
Event Type  Injury  
Manufacturer Narrative
The cycler was returned for investigation and passed all testing.The cycler was performing as designed and intended.A device history record (dhr) review was conducted for the cycler which met all manufacturing requirements and specifications prior to release of the unit.A cartridge dhr review showed there were no related issues and no quality issues found during the manufacture of this lot.Factors outside the scope of nxstage therapy can impact the patient''s weight.These include but are not limited to the accuracy with which intake is recorded, the weighing techniques used and the patient's comorbidities.Udi number (b)(4).
 
Event Description
A report was received on (b)(6) 2017 from the caregiver of a (b)(6) male patient who stated the patient reported shortness of breath following a standard hemodialysis treatment on (b)(6) 2017.The patient was hospitalized on (b)(6) 2017 and received hemodialysis to remove excess fluid.Additional information received on august 4, 2017 from the director of home therapies at the facility, stated the hospitalization for fluid removal was related to patients non-compliance and unrelated to nxstage products or therapy.Follow-up information received on august 10, 2017 from the staff at the facility indicated that the patient was released from hospital on (b)(6) 2017 and is continuing standard home hemodialysis without issue.The patient's comorbidities included end stage renal disease, hypertension, hyperlipidemia, and type ii diabetes mellitus.Despite the patient¿s comorbidities a relationship to nxstage products could not be ruled out by the patient¿s physician.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NXSTAGE SYSTEM ONE
Type of Device
HIGH PERMEABILITY HEMODIALYSIS SYSTEM
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
350 merrimack street
lawrence MA 01843
Manufacturer (Section G)
MEDIMEXICO S. DE R. L. DE C. V
av. valle imperial no. 10523
parque industrial valle sur
tijuana 22180
MX   22180
Manufacturer Contact
paula rogalski
nxstage medical, inc
350 merrimack street
lawrence, MA 01843
9786874700
MDR Report Key6835576
MDR Text Key84267489
Report Number3003464075-2017-00042
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
PMA/PMN Number
K122051
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Patient
Type of Report Initial
Report Date 08/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberNX1000-3
Device Catalogue NumberCHRONIC HI-FLOW CYCLER
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/07/2017
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/10/2017
Initial Date FDA Received08/31/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/03/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age54 YR
Patient Weight121
-
-